WBA Valuation Metrics
WBA Stock Price Metrics
WBA Dividend Metrics
WBA Growth Rate Metrics
WBA Discounted Cash Flow Metrics
| Fair Value Price | - |
| Margin of Safety | - |
WBA Revenue Metrics
WBA PE Ratio Metrics
| PE Ratio | 31.85 |
| PE Ratio Avg TTM | 33.48 |
| PE Ratio Avg 3Y | 14.63 |
| Current VS TTM Avg | -4.86% |
| Current VS 3Y Avg | +117.73% |
| Current VS 5Y Avg | +27.01% |
WBA PS Ratio Metrics
| PS Ratio | 0.07 |
| PS Ratio Avg TTM | 0.06 |
| PS Ratio Avg 3Y | 0.13 |
| Current VS TTM Avg | +19.20% |
| Current VS 3Y Avg | -47.05% |
| Current VS 5Y Avg | -65.06% |
WBA PB Ratio Metrics
| PB Ratio | 1.44 |
| PB Ratio Avg TTM | 1.00 |
| PB Ratio Avg 3Y | 0.99 |
| Current VS TTM Avg | +43.59% |
| Current VS 3Y Avg | +44.96% |
| Current VS 5Y Avg | +11.76% |
WBA Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 17.86 |
| PFCF Ratio Avg TTM | 17.13 |
| PFCF Ratio Avg 3Y | 29.64 |
| Current VS TTM Avg | +4.28% |
| Current VS 3Y Avg | -39.74% |
| Current VS 5Y Avg | +1.35% |
WBA Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 3.23 |
| Debt/Equity Ratio Avg TTM | 2.45 |
| Debt/Equity Ratio Avg 3Y | 1.88 |
| Current VS TTM Avg | +31.84% |
| Current VS 3Y Avg | +72.04% |
| Current VS 5Y Avg | +91.69% |
WBA PEG Ratio Metrics
| PEG Ratio | - |
| PEG Ratio Avg TTM | 0.05 |
| PEG Ratio Avg 3Y | 0.05 |
| Current VS TTM Avg | - |
| Current VS 3Y Avg | - |
| Current VS 5Y Avg | - |
WBA FCF Yield
| FCF Yield | 5.60% |
| FCF Yield Avg TTM | 5.84% |
| FCF Yield Avg 3Y | 5.45% |
| Current VS TTM Avg | -4.16% |
| Current VS 3Y Avg | +2.73% |
| Current VS 5Y Avg | -34.21% |
WBA Earnings Yield
| Earnings Yield | 3.14% |
| Earnings Yield Avg TTM | 3.00% |
| Earnings Yield Avg 3Y | 10.30% |
| Current VS TTM Avg | +4.79% |
| Current VS 3Y Avg | -69.51% |
| Current VS 5Y Avg | -62.98% |
WBA EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 47.97 |
| Ev/Ebit Ratio Avg TTM | 25.59 |
| Ev/Ebit Ratio Avg 3Y | 34.39 |
| Current VS TTM Avg | +87.48% |
| Current VS 3Y Avg | +39.47% |
| Current VS 5Y Avg | +91.82% |
WBA EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 20.96 |
| Ev/Ebitda Ratio Avg TTM | 21.34 |
| Ev/Ebitda Ratio Avg 3Y | 19.40 |
| Current VS TTM Avg | -1.77% |
| Current VS 3Y Avg | +8.03% |
| Current VS 5Y Avg | +9.80% |
WBA EV/Assets Ratio Metrics
| Ev/Assets Ratio | 0.56 |
| Ev/Assets Ratio Avg TTM | 0.52 |
| Ev/Assets Ratio Avg 3Y | 0.58 |
| Current VS TTM Avg | +7.61% |
| Current VS 3Y Avg | -3.81% |
| Current VS 5Y Avg | -19.14% |
WBA EV/Sales Ratio Metrics
| Ev/Sales Ratio | 0.25 |
| Ev/Sales Ratio Avg TTM | 0.26 |
| Ev/Sales Ratio Avg 3Y | 0.37 |
| Current VS TTM Avg | -5.35% |
| Current VS 3Y Avg | -31.99% |
| Current VS 5Y Avg | -44.96% |
WBA Current Ratio Metrics
| Current Ratio | 0.68 |
| Current Ratio Avg TTM | 0.66 |
| Current Ratio Avg 3Y | 0.70 |
| Current VS TTM Avg | +3.82% |
| Current VS 3Y Avg | -2.16% |
| Current VS 5Y Avg | -2.39% |
WBA Quick Ratio Metrics
| Quick Ratio | 0.37 |
| Quick Ratio Avg TTM | 0.33 |
| Quick Ratio Avg 3Y | 0.35 |
| Current VS TTM Avg | +10.45% |
| Current VS 3Y Avg | +5.71% |
| Current VS 5Y Avg | +6.73% |
WBA ROIC Metrics
| ROIC | (24.28%) |
| ROIC Avg 3Y | (6.38%) |
| ROIC Avg 5Y | (2.73%) |
| Current VS 3Y Avg | +280.56% |
| Current VS 5Y Avg | +788.83% |
| Current VS 10Y Avg | -1051.14% |
WBA Return on Assets Metrics
| ROA | (10.66) |
| ROA Avg TTM | (6.92) |
| ROA Avg 3Y | (1.48) |
| Current VS TTM Avg | +53.94% |
| Current VS 3Y Avg | +621.49% |
| Current VS 5Y Avg | -14313.33% |
WBA Return on Equity Metrics
| ROE | (82.68) |
| ROE Avg TTM | (49.03) |
| ROE Avg 3Y | (18.16) |
| Current VS TTM Avg | +68.63% |
| Current VS 3Y Avg | +355.41% |
| Current VS 5Y Avg | +819.18% |
WBA Net Profit Margin Metrics
| Net Profit Margin | (5.85%) |
| Net Profit Margin Avg TTM | (4.03%) |
| Net Profit Margin Avg 3Y | (0.72%) |
| Current VS TTM Avg | +45.16% |
| Current VS 3Y Avg | +715.33% |
| Current VS 5Y Avg | -4380.49% |
Last Updated: Saturday, June 13, 2026
About Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc., established in 1901 and based in Deerfield, Illinois, operates as a leading global retailer focused on pharmacy, health, and beauty products. Its business activities are organized into two primary divisions: the United States and International. In the United States, the company dispenses prescription drugs and offers a diverse selection of retail goods. This includes items for health, wellness, beauty, and personal care, alongside general merchandise and consumable products, all available through its extensive network of retail drugstores. The U.S. segment also provides specialized central pharmacy services and mail delivery options for prescriptions. As of August 31, 2021, this division managed 8,965 retail outlets under the Walgreens and Duane Reade banners, complemented by five specialty pharmacies. The International segment focuses on the sale of prescription medications, health and wellness items, beauty products, personal care essentials, and other consumer goods. These are sold through its pharmacy-centric health and beauty retail locations, optical practices, its online platform boots.com, and an integrated mobile application. Additionally, this segment engages in pharmaceutical wholesale and distribution operations within Germany. By August 31, 2021, the international portfolio included 4,031 retail stores operating under brands such as Boots, Benavides, and Ahumada, located across countries including the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. It also oversaw 548 optical practices, with 160 of these operating as franchises.
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Timothy C. Wentworth